Skip to main content
. Author manuscript; available in PMC: 2014 Feb 11.
Published in final edited form as: Int J Clin Rheumtol. 2013 Feb;8(1):137–146. doi: 10.2217/ijr.12.82

Table 1.

Treatment guidelines for cytomegalovirus infection in childhood-onset systemic lupus erythematosus

Category of infection Antiviral therapies Adjunctive management
CMV infection: primary or secondary Consider pre-emptive treatment based on viral DNA copy number and clinical situation (no definitive threshold for treatment based on DNA copy number) Follow viral load
Consider modifying immunosuppression if feasible
CMV syndrome Treat: iv. gancyclovir first line; foscarnet and others if intolerant Monitor immunosuppressants
Consider CMV IVIg (Cytogam®)
CMV disease Treat: iv. gancyclovir first line; foscarnet and others if intolerant Consider modifying immunosuppression if feasible
Consider CMV IVIg (Cytogam)

CMV: Cytomegalovirus; iv.: Intravenous; IVIg: Intravenous immunoglobin.